about
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobron...
Read More
1.28
-0.08
(-5.88%)
49,844.7
XNAS Volume
XNAS 07 Apr, 2026 12:44 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks have poor scores across the board. Investors should be very cautious with these stocks
View Similar
Embed DVM
Pulmonx Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..